References:
Akpunonu P, Baum RA, Reckers A, et al. Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies. Am J Case Rep 2021;22:e933488. View abstract.
Akpunonu P, Baum RA, Reckers A, et al. Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies. Am J Case Rep 2021;22:e933488. View abstract.
Avraham Y, Ben-Shushan D, Breuer A, et al. Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss. Pharmacol Biochem Behav 2004;77(4):675-84. View abstract.
Avraham Y, Ben-Shushan D, Breuer A, et al. Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss. Pharmacol Biochem Behav 2004;77(4):675-84. View abstract.
Centers for Disease Control and Prevention (CDC). Increases in availability of cannabis products containing delta-8 THC and reported cases of adverse events. September 2021. https://emergency.cdc.gov/han/2021/han00451.asp. Accessed October 2, 2021.
Centers for Disease Control and Prevention (CDC). Increases in availability of cannabis products containing delta-8 THC and reported cases of adverse events. September 2021. https://emergency.cdc.gov/han/2021/han00451.asp. Accessed October 2, 2021.
Crippa JAS, Zuardi AW, Hallak JEC, et al. Oral cannabidiol does not convert to ?(8)-THC or ?(9)-THC in humans: A pharmacokinetic study in healthy subjects. Cannabis Cannabinoid Res 2020;5(1):89-98. View abstract.
Crippa JAS, Zuardi AW, Hallak JEC, et al. Oral cannabidiol does not convert to ?(8)-THC or ?(9)-THC in humans: A pharmacokinetic study in healthy subjects. Cannabis Cannabinoid Res 2020;5(1):89-98. View abstract.
Czégény Z, Nagy G, Babinszki B, et al. CBD, a precursor of THC in e-cigarettes. Sci Rep 2021;11(1):8951. View abstract.
Czégény Z, Nagy G, Babinszki B, et al. CBD, a precursor of THC in e-cigarettes. Sci Rep 2021;11(1):8951. View abstract.
Jo NY, Chu CC, Ramsey BC. Brugada Electrocardiogram Pattern Induced by Recreational Delta-8-Tetrahydrocannabinol (THC): A Case Report. Cureus 2021;13(10):e19058. View abstract.
Jo NY, Chu CC, Ramsey BC. Brugada Electrocardiogram Pattern Induced by Recreational Delta-8-Tetrahydrocannabinol (THC): A Case Report. Cureus 2021;13(10):e19058. View abstract.
Johnson-Arbor K, Smolinske S. The current state of delta-8 THC. Am J Emerg Med 2021. View abstract.
Johnson-Arbor K, Smolinske S. The current state of delta-8 THC. Am J Emerg Med 2021. View abstract.
Loveless SE, Harris LS, Munson AE. Hyporesponsiveness to the immunosuppressant effects of delta-8-tetrahydrocannabinol. J Immunopharmacol 1981;3(3-4):371-83. View abstract.
Loveless SE, Harris LS, Munson AE. Hyporesponsiveness to the immunosuppressant effects of delta-8-tetrahydrocannabinol. J Immunopharmacol 1981;3(3-4):371-83. View abstract.
Meehan-Atrash J, Rahman I. Novel ?(8)-Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals. Chem Res Toxicol 2021. View abstract.
Meehan-Atrash J, Rahman I. Novel ?(8)-Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals. Chem Res Toxicol 2021. View abstract.
Rosenthal J, Howell M, Earl V, Malik M. Cannabinoid hyperemesis syndrome secondary to delta-8 THC use. Am J Med 2021. View abstract.
Rosenthal J, Howell M, Earl V, Malik M. Cannabinoid hyperemesis syndrome secondary to delta-8 THC use. Am J Med 2021. View abstract.
Rzeppa S, Große J, Rautenberg C, et al. Emergence of the less common cannabinoid ?8 -Tetrahydrocannabinol in a doping sample. Drug Test Anal. 2021. View abstract.
Rzeppa S, Große J, Rautenberg C, et al. Emergence of the less common cannabinoid ?8 -Tetrahydrocannabinol in a doping sample. Drug Test Anal. 2021. View abstract.
Stout SM, Cimino NM. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metab Rev. 2014;46(1):86-95. View abstract.
Stout SM, Cimino NM. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review. Drug Metab Rev. 2014;46(1):86-95. View abstract.
US Food and Drug Administration (FDA). 5 things to know about delta-8 tetrahydrocannabinol - delta-8 THC. September 2021. https://www.fda.gov/consumers/consumer-updates/5-things-know-about-delta-8-tetrahydrocannabinol-delta-8-thc. Accessed October 2, 2021.
US Food and Drug Administration (FDA). 5 things to know about delta-8 tetrahydrocannabinol - delta-8 THC. September 2021. https://www.fda.gov/consumers/consumer-updates/5-things-know-about-delta-8-tetrahydrocannabinol-delta-8-thc. Accessed October 2, 2021.
Watanabe K, Arai M, Narimatsu S, Yamamoto I, Yoshimura H. Effect of repeated administration of 11-hydroxy-delta 8-tetrahydrocannabinol, an active metabolite of delta 8-tetrahydrocannabinol, on the hepatic microsomal drug-metabolizing enzyme system of mice. Biochem Pharmacol 1986;35(11):1861-5. View abstract.
Watanabe K, Arai M, Narimatsu S, Yamamoto I, Yoshimura H. Effect of repeated administration of 11-hydroxy-delta 8-tetrahydrocannabinol, an active metabolite of delta 8-tetrahydrocannabinol, on the hepatic microsomal drug-metabolizing enzyme system of mice. Biochem Pharmacol 1986;35(11):1861-5. View abstract.